Prognostic factors for metastatic colorectal cancer patients undergoing irinotecan-based second-line chemotherapy.

作者
Kohei Shitara,Keitaro Matsuo,Tomoya Yokota,Daisuke Takahari,Takashi Shibata,Takashi Ura,Yoshitaka Inaba,Hidekazu Yamaura,Yozo Sato,Mina Najima,Kei Muro
出处
期刊:PubMed [National Institutes of Health]
卷期号:4 (5-6): 168-72 被引量:22
标识
摘要

BACKGROUND: No reports about factors that predict prognosis after second-line chemotherapy for metastatic colorectal cancer have been published. METHODS: We retrospectively analyzed 124 patients with metastatic colorectal cancer who received irinotecan-based second-line chemotherapy after first-line folinic acid/5-fluorouracil (5-FU)/oxaliplatin (FOLFOX) with or without bevacizumab. RESULTS: A multivariate Cox model revealed 5 prognostic factors for worse survival: ECOG performance status 2, pathologically poorly differentiated adenocarcinoma, peritoneal metastasis, progression-free survival of first-line FOLFOX < 6 months, and lactate dehydrogenase ≥ 400 IU/L. When patients were categorized into 3 risk groups-patients without any prognostic factors (low-risk, n = 55), patients with one prognostic factor (intermediate-risk, n = 32), and patients with 2 or more prognostic factors (high-risk, n = 37)-overall survival from initiation of second-line chemotherapy was 23.5, 14.6, and 5.5 months, respectively. The proportion of patients who were eligible to receive further chemotherapy after disease progression was significantly lower in the high-risk group (41%) than in the intermediate- (67%) and low-risk (95%) groups. CONCLUSION: Several prognostic factors for survival after second-line therapy and probability of receiving third-line chemotherapy were identified. This risk classification system might be useful for determining which patients should receive cetuximab in the second-line setting rather than the third-line setting.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
施不评发布了新的文献求助10
刚刚
美好觅松的应助被白色采纳,获得30
1秒前
内向的万言完成签到 ,获得积分10
2秒前
2秒前
喻紫寒完成签到 ,获得积分10
3秒前
烟花的应助被2170245404采纳,获得10
3秒前
3秒前
田様的应助被十七采纳,获得10
3秒前
秀丽静曼发布了新的文献求助10
3秒前
郝柿橙双发布了新的文献求助10
3秒前
张张完成签到,获得积分10
4秒前
领导范儿的应助被九万里采纳,获得10
4秒前
5秒前
一颗苹果的应助被zhang采纳,获得10
5秒前
慕青的应助被幽默的初瑶采纳,获得10
5秒前
6秒前
plj发布了新的文献求助10
6秒前
项空月发布了新的文献求助10
6秒前
7秒前
天羽纵梦完成签到,获得积分10
7秒前
努力且幸运完成签到,获得积分10
7秒前
8秒前
march完成签到,获得积分10
8秒前
8秒前
可爱的函函的应助被DDZ采纳,获得10
9秒前
9秒前
961发布了新的文献求助10
10秒前
无心的柚子完成签到,获得积分10
10秒前
无情醉易完成签到,获得积分20
11秒前
11秒前
端庄烧鹅发布了新的文献求助10
11秒前
ayzzdbr发布了新的文献求助10
11秒前
12秒前
12秒前
体贴的平文完成签到,获得积分10
12秒前
Believer发布了新的文献求助10
12秒前
项空月完成签到,获得积分10
12秒前
Lucas的应助被yys采纳,获得10
12秒前
喵姐完成签到,获得积分10
13秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
Resource Recovery Handbook 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8175534
求助须知:如何正确求助?哪些是违规求助? 9567220
关于积分的说明 21791292
捐赠科研通 7770111
什么是DOI,文献DOI怎么找? 3431868
关于科研通互助平台的介绍 2556244
邀请新用户注册赠送积分活动 2477299